Kolexia
De Ledinghen Victor Gastro-entérologie
De Ledinghen Victor
Gastro-entérologie
Hôpital Haut-lévêque
Pessac, France
641 Activités
1.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cirrhose du foie Fibrose Hépatite Hépatite C Hépatite C chronique Maladies du foie Stéatose hépatique non alcoolique Stéatose hépatique Hépatite chronique

Collaborateurs

Voir plus
Bourliere Marc
Bourliere Marc
Hopital Saint Joseph, Marseille, France
Leroy Vincent
Leroy Vincent
Hôpital Henri Mondor, Créteil, France
Pol Stanislas
Pol Stanislas
Hôpital Cochin, Paris, France
Boursier Jerome
Boursier Jerome
Hôpital Larrey Angers, Angers, France

Industries

Voir plus
Gilead
48 collaboration(s)
Dernière en 2023
Abbvie
21 collaboration(s)
Dernière en 2023
B3TSI
6 collaboration(s)
Dernière en 2021
BMS
6 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
HORIZON: 17 β-Hydroxysteroid Dehydrogenase Type 13 Minimization for the Treatment of NASH (HORIZON): A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults With Nonalcoholic Steatohepatitis
Essai Clinique (GSK)   13 mars 2024
PRO-SURFASA: Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis, a National Prospective Multicentre Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   11 mars 2024
CARVECIR: Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
Essai Clinique (CHU Tours)   16 février 2024
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
NATiV3: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
Essai Clinique (Inventiva Pharma)   24 janvier 2024
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Hepatology (Baltimore, Md.)   22 janvier 2024
SCREANIT: SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population
Essai Clinique (CHU Angers)   08 janvier 2024
Reply: Improving access to transient elastography data for Real-World Prognostic Applications in primary biliary cholangitis.
Hepatology (Baltimore, Md.)   27 décembre 2023
Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease.
United European gastroenterology journal   21 novembre 2023